Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC007 vs efavirenz plus lamivudine and tenofovir in treatment‑naïve HIV-1 infection
CTR20181797Phase 3Completed
- Sponsor
- Aidea Pharma
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ainuovirine in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by Aidea Pharma. Started Oct 2018; status: completed.
02
Drugs
ainuovirine
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on CTR20181797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181797.